Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Stem Cell Therapy for Osteoarthritis Supply, Demand and Key Producers, 2024-2030

date 29 Mar 2024

date Pharma & Healthcare

new_biaoQian Stem Cell Therapy for Osteoarthritis

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.

USD4480.00

Add To Cart

Add To Cart

Global Stem Cell Therapy for Osteoarthritis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 29 Mar 2024

date Pharma & Healthcare

new_biaoQian Stem Cell Therapy for Osteoarthritis

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.

USD3480.00

Add To Cart

Add To Cart

Global Stem Cell Therapy for Osteoarthritis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Stem Cell Therapy for Osteoarthritis

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.

USD3480.00

Add To Cart

Add To Cart

industry 29 Mar 2024

industry Pharma & Healthcare

new_biaoQian Stem Cell Therapy for Osteoarthritis

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.

USD4480.00

addToCart

Add To Cart

industry 29 Mar 2024

industry Pharma & Healthcare

new_biaoQian Stem Cell Therapy for Osteoarthritis

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Stem Cell Therapy for Osteoarthritis

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.

USD3480.00

addToCart

Add To Cart